Nuclear export of phosphorylated C/EBPβ mediates the inhibition of albumin expression by TNF-α

EMBO Journal

Volumn 20, Issue 23, 2001, Pages 6712-6723

  Buck, Martina ^a,b   Zhang, Lian ^b,c   Halasz, Nicholas A ^c,d   Hunter, Tony ^a   Chojkier, Mario ^b,c  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

AIDS; Albumin; Cancer; NOS; Oxidative stress

Indexed keywords

ALANINE; ALBUMIN; ANTIOXIDANT; LEPTOMYCIN B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL CELL; ARTICLE; CACHEXIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT;

EID: 0035803399     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.23.6712     Document Type: Article

References (74)

1. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family
2. Biology of multifunctional cytokines; IL 6 and related molecules (IL and TNF)
3. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene activation in the liver
4. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates
5. Edema
6. Tumor necrosis factor α inhibits albumin gene expression in a murine model of cachexia
7. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants
8. LAP (NF-IL6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation
9. 1(I) gene expression and wound healing in a murine model of cachexia
10. Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBPβ is required for hepatocyte proliferation induced by TGFα
11. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells
12. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver
13. Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNFα transgenic mice
14. Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein β. A critical role for protein kinase A-mediated phosphorylation or Ser299
15. Regulation of liver-specific gene expression
16. Long- and short-term D-α-tocopherol supplementation, inhibits liver collagen α1(I) gene expression
17. CCAAT/enhancer binding protein gene promoter: Binding of nuclear factors during differentation of 3T3-L1 preadipocytes
18. Persistent inhibition of cell respiration by nitric oxide: Crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione
19. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein
20. Regenerative changes in C/EBPα and C/EBPβ modulate expression binding to the C/EBP site in the c-fos promoter
21. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of IL-1
22. Nitric oxide regulates cyclic GMP-dependent protein kinase phosphorylation in rat brain
23. Infusion of tumor necrosis/cachectin promotes muscle catabolism in the rat: A synergistic effect with interleukin 1
24. Cachectin/TNF or IL-1 induces cachexia with redistribution of body proteins
25. Cytokines, endotoxin and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes
26. Elevation of tumor necrosis factor in head injury
27. Tumor necrosis factor and disease severity in children with Falciparum malaria
28. CCAAT enhancer-binding protein β is required for normal hepatocyte proliferation in mice after partial hepatectomy
29. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome
30. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB
31. Transcriptional regulation. Modification of nuclear export?
32. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload
33. Two different cis-acting regulatory regions direct cell-specific transcription of the collagen α(I) gene in hepatic stellate cells and in skin and tendon fibroblasts
34. Nitric oxide regulation of gene transcription via soluble guanylate cyclase and type I cGMP-dependent protein kinase
35. The NF-M transcription factor is related to C/EBPβ and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells
36. Construction and cloning of rat albumin structural gene sequences
37. Nitric oxide in skeletal muscle
38. p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene
39. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region
40. Isolation of a recombinant copy of the gene encoding C/EBP
41. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
42. The role of cis-acting promoter elements in tissue-specific albumin gene expression
43. Inducible nitric oxide synthase expression in chronic viral hepatitis
44. Nucleocytoplasmic transport: The soluble phase
45. The role of phosphorylation and the CDC28 protein kinase in cell cycle-regulated nuclear import of the S.cerevisiae transcription factor SW15
46. DBP, a liver-enriched transcriptional activator, is expressed late in ontogeny and its tissue specificity is determined posttranscriptionally
47. The direction of transport through the nuclear pore can be inverted
48. Tumors secreting human TNFα/cachectin induce cachexia in mice
49. Evidence for a role of CRM1 in signal-mediated nuclear protein export
50. IL6-DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP
51. Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation
52. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery
53. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF
54. Lymphoproliferative disorder and imbalanced T-helper response in C/EBPβ-deficient mice
55. Raised serum levels of tumor necrosis factor in parasitic infections
56. Through thick and thin: Wasting, obesity and TNFα
57. Redox signaling: Nitrosylation and related interactions of nitric oxide
58. Evidence for the involvement of interleukin 6 in experimental cancer cachexia
59. Characterization of a cancer cachectic factor
60. Tumor necrosis factor, other cytokines and disease
61. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production
62. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain
63. Protein kinase A and C site-specific phosphorylations of LAP (NF-IL6) modulate its binding affinity to DNA-recognition elements
64. Differential gene expression of IFN-α and tumor necrosis factor-α in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS
65. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease
66. Impaired energy homeostasis in C/EBPα knockout mice
67. C/EBP proteins contain nuclear localization signals imbedded in their basic regions
68. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor
69. Rapid communication: Nucleotide sequence of bovine C/EBPβ gene
70. Tumor necrosis factor α promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes
71. Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia and leukocytosis in a human tumor in nude mice
72. Genetic control of hepatocyte differentiation